Clinical-spotlight
Food and Drug Administration
advisory committee (US FDA) unanimously recommend the third shots to people age
65 and older and those at a high risk of suffering from severe illness if they
get the coronavirus.
Rejected a proposal to distribute
booster/third shots of Pfizer and BioNTech’s Covid-19 vaccine to the General Public. RemoveA...
This WHO Therapeutics and COVID-19: living guideline now includes two recommendations regarding the combination of neutralizing monoclonal antibodies, Casirivimab and Imdevimab: a conditional recommendation in favour of use in non-severe patients (the condition being patients’ risk of severe disease: patients at highest risk represent good candidat...
Key facts
Antibiotic
resistance is one of the biggest threats to global health, food security,
and development today.
Antibiotic
resistance can affect anyone, of any age, in any country.
Antibiotic
resistance occurs naturally, but misuse of antibiotics in humans and
animals is accelerating the process.
A gr...
Revised guideline for clinical
management of Dengue4th Edition 2018, Revised
(Printed May, 2020)
The draft version of revised
guideline for clinical management of Dengue. The revised guideline contains new
conception regarding pediatric management as well as management of Dengue in
pregnancy. Dengue in Covid19 context has been briefly d...
Novel Coronavirus (COVID-19)
Guidelines of Bangladesh.
The guidelines for the diagnosis,
treatment, and control of the coronavirus disease (COVID-19).
More good news! In addition to last week’s announcement of very high (90%) COVID-19 vaccine efficacy emerging from the first interim analysis of a phase 3 trial [1], we received word that a second vaccine had similar initial efficacy at 94.5%.[2] Both of these candidates use an mRNA platform, a novel approach to human vaccines. Th...
Results from the meta-analysis of 48 trials demonstrated
that even a small reduction in systolic blood pressure (just 5 mm Hg) could
reduce the risk of cardiovascular events by 10%, and even at normal or
high-normal blood pressure values.
These findings suggest that a fixed degree of
pharmacological blood pressure lowering is similarly effec...
The COVID-19 Treatment Guidelines have been developed to
inform clinicians how to care for patients with COVID-19. Because clinical
information about the optimal management of COVID-19 is evolving quickly.
The recommendations in these Guidelines are based on scientific
evidence and expert opinion. Each recommendation includes two...
This guidance document is
intended for clinicians caring for COVID-19 patients during all phases of their
disease (i.e., screening to discharge). This update has been expanded to
meet the needs of front-line clinicians and promotes a multi-disciplinary
approach to care for patients with COVID-19, including those with mild,
moderate, severe, a...
The U.S. Food and Drug
Administration issued an emergency use authorization (EUA) for the drug
baricitinib, in combination with remdesivir, for the treatment of suspected or
laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two
years of age or older requiring supplemental oxygen, invasive mechanical...
National guidelines version 8th on clinical management of Coronavirus
disease by Disease Control Division, Directorate General of Health
Services, Ministry of Health & Family Welfare & Government of the
People's Republic of Bangladesh.
The guideline includes clinical management of COVID-19 and
is updated with the latest evide...
An Aid to the Management of
COVID-19 in Bangladesh: “Lessons from the western experience” New 5th Edition
This book is a small effort by
some highly-motivated Bangladeshi doctors living in the UK and the USA to
supplement local guidelines in Bangladesh. This will hopefully enable local
experts in Bangladesh to be kept updated...
